1. AI in Clinical Trials—Case Studies & Lessons From Real Implementations, Featuring a Fireside Chat with Eli Lilly
Artificial intelligence (AI) is reshaping the clinical trial landscape,and this session offers an exclusive look at its transformative potential through real-world case studies.
Wed, Feb 5 at 9:55 amWhat you'll learn
- Proven Use Cases: Discover the top AI applications driving measurable improvements in clinical trial operations.
- Lessons From Industry Leaders: Hear directly from Eli Lilly’s experts about how they’ve leveraged AI to create digital full-time equivalent (FTE) capacity, transforming clinical development processes.
- Navigating Challenges: Learn about the potential risks of AI adoption and how to overcome them effectively.
Featured Speakers
Siddhartha Bhattacharya, Life Sciences AI Leader, PwC
Lora Todd, VP of Emerging Tech and Information Management, Eli Lilly
Mike Luker, VP of Data & Analytics, Clinical Development, Eli Lilly
2. Opportunities for AI, RWD, and People to Power Trial Optimization
AI and real-world data (RWD) are transforming trial feasibility assessments. Learn how these tools integrate into trial optimization and foster cross-functional collaboration.
Tues, Feb. 4 at 11:35 amWhat you'll learn
- How to integrate AI and real-world data (RWD) for optimizing trial feasibility assessments.
- Practical steps for using AI alongside RWD to streamline processes.
- Strategies for fostering cross-functional collaboration to innovate trial feasibility.
Featured Speakers
Desiree Abu-Odeh, PhD, MPH, Senior Scientist, Global Trial Optimization, Merck
Dana Wheeler, Associate Principal Scientist, Global Trial Optimization, Merck
3. Panel Discussion: Redesigning Site Contract and Budget Negotiations to Accelerate Study Start-Up
Streamlining contract and budget negotiations is key to accelerating study start-up. This session provides actionable strategies to simplify these critical processes.
Tues, Feb. 4 at 11:35 amWhat you'll learn
- Best practices for faster contract and budget negotiations.
- Collaborative approaches to balancing sponsor and site needs.
- Strategies for aligning budgets with trial goals to reduce delays.
Featured Speakers
Jennifer Sydney Goldman, Consultant, Clinical Business Operations
Jenn Hill, Director, Clinical Site Contracting and Payments, Vertex Pharmaceuticals
Erik Sokolowski, Senior Director, Global Trial Optimization, Alnylam Pharmaceuticals
Serpil Tutan, Director, Clinical Research, Baylor College of Medicine
Moderator: Debora Sobral, Director, Site Budget Management, Kyowa Kirin
4. Keynote: Fostering Clinical Innovation in a Large Pharmaceutical Organization
How can pharma giants stay agile and innovative? April Lewis offers a roadmap focusing on four key areas for fostering creativity and building a culture of innovation within large organizations.
Wed, Feb 5 at 2:37 pmWhat you'll learn
- Building infrastructure and teams to support creativity in clinical trials.
- Driving patient-centricity through innovative research methods.
- Aligning organizational goals with groundbreaking healthcare outcomes.
Featured Speaker
April Lewis, Head, Innovative Health, Global Development, Johnson & Johnson
5. Future of Medicine Community Health Screening: A Revolutionary Approach to Enrolling Clinical Trials
Recruitment challenges remain a major hurdle in clinical trials. This session showcases a groundbreaking “always-on” pre-screening model to improve recruitment and connect patients to multiple trials simultaneously.
Wed, Feb 5 at 12:25 pmWhat you'll learn
- How the "always-on" pre-screening approach transforms recruitment economics.
- The role of community health screenings in improving education and access to clinical research.
- How you can help bring Future of Medicine to communities around the world
Featured Speaker
Ralph Passarella, Co-Founder, Care Access
6. Accelerating Drug Development through Clinical Trial Delivery Innovation
Hybrid and decentralized trials are the future. Learn how innovative research methods are reshaping patient engagement and reducing investigator burden.
Tues, Feb. 4 at 11:05 amWhat you'll learn
- Key lessons from decentralized and hybrid trial strategies.
- Reducing patient and investigator burden through innovative methods.
- Examples of successful implementation and their future applications.
Featured Speaker
Kim O'Day, Senior Director, Emerging Technology Operations, Eli Lilly
7. Workshop: Efficient Importation of Biological Materials into the U.S.
Importing biological materials into the U.S. can be a logistical minefield. This workshop offers insights into navigating regulations and ensuring smooth importation.
Mon, Feb. 3 at 1 pmWhat you'll learn
- Navigating the regulatory landscape for importing biological materials.
- Best practices for streamlining the importation process.
- Collaborative strategies to overcome logistical challenges.
Instructors
Jessica Hammes, Branch Chief, U.S. Customs and Border Protection
Jennifer Merriman, Senior Manager, Bristol Myers Squibb Co.
8. Leveraging RBQM Technologies to Achieve Diversity Action Plan Goal
Diversity is a cornerstone of modern trials. This session highlights how RBQM technologies can help implement and monitor Diversity Action Plans.
Wed, Feb 5 at 9:15 amWhat you'll learn
- Using RBQM technologies to develop and execute Diversity Action Plans.
- Insights from case studies on diversity-focused monitoring.
- Strategies for inclusive trial oversight and execution.
Featured Speakers
Damalie Akuamoah, Diversity Program Lead, Merck
Naveen KK, Vice President, Fortrea
Lydia Matombo, Director, Merck & Co.
9. Panel Discussion: Scaling CGT – Cracking the Supply Chain Code
Scaling cell and gene therapies is a complex but essential challenge. Learn how to build a robust supply chain without compromising product integrity.
Wed, Feb 5 at 12:25 pmWhat you'll learn
- Overcoming scaling challenges in the CGT supply chain.
- Maintaining cell viability and quality during production.
- Collaborative strategies across stakeholders to ensure successful outcomes.
Featured Speakers
Christine M. Fernandez, Consultant, Cell & Gene Therapy
Michael Mehler, Director, Cell Therapy Operations, AstraZeneca
Cara Woodruff, Director, IQVIA Technologies
Moderator: Lee Buckler, Senior Vice President, Blood Centers of America
10. LUNCHEON PRESENTATION: Future of Medicine: Community Health Screenings and Research Education Across America
This presentation will highlight how a community-driven approach is fostering greater diversity in research while bringing advanced health screenings and study opportunities to underserved populations nationwide.
Wed, Feb 5 at 1:30 pmWhat you'll learn
- Insights into how community health screenings increase access to clinical trials and research education.
- Real-world examples of the program’s success in making clinical trials more inclusive.
- Opportunities to explore how this innovative model can be applied in your organization.
Featured Speaker
Jennifer Hillner, Vice President, Strategic Accounts, Care Access
The future of clinical trials is being written by the innovators who ask bold questions and embrace transformative solutions. These sessions bring together the best minds in clinical research, offering a unique space to share ideas, tackle challenges, and create a brighter future for clinical trials. Join the conversation, challenge the status quo, and help drive real progress in patient care and research efficiency.
See you there!
Stop by the Care Access booth 503 at the SCOPE Summit. You could win exciting prizes while learning about our innovative solutions. Exhibit Hall Floor Map.